1Spronk HM,Govers-Riemslag JW,ten Cate H.The bloocoagulation system as a molecular machine[J].Bioessays,2003,25:1220-1228.
2Ohnishi M,Katsuki H,Fujimoto S,et al.Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury[J].Exp Neurol,2007,206(1):43-52.
3Hohnke C,Haas S.Two surgical case reports showing atypical heparin-induced thrombocytopenia[J].Chirurg,2007,78(2):138,140-1.
8Eriksson BI,Arfwidsson AC,Frison L,et al.A dose rangin study of the oral direct thrombin inhibitor,ximelagatran,anits subcutaneous form,melagatran,compared with daltepari in the prophylaxis of thromboembolism after hip or knee replacement:Methro I.Melagatran for Thrombin inhibition in Orthopaedic surgery[J].Thromb Haemost,2002,87:231-237.
9Grant PJ.Is hypercoagulability an issue in arterial thrombosis?[J].Yes.J Thromb Haemost,2004(2):690-691.
10Van Aken H, Bode C, Darius H, et al. Anticoagulation: the present and future. Clin Appl Thromb Hemost, 2001,7: 195-204.
